BioAtla (BCAB) Assets Average (2021 - 2026)
BioAtla (BCAB) posted quarterly Assets Average of $10.1 million for Q4 2025, down 82.39% year-over-year from $57.3 million in Q4 2024, and down 53.08% quarter-over-quarter from $21.5 million in Q3 2025.
BioAtla (BCAB) Assets Average (2021 - 2026) Analysis & Trends
BioAtla's Assets Average history runs 5 years deep, the most recent figure standing at $10.1 million for Q4 2025.
- In Q4 2025, Assets Average fell 82.39% year-over-year to $10.1 million; the TTM figure through Dec 2025 stood at $10.1 million (down 82.39% YoY), while the FY2025 annual figure was $28.4 million, down 67.05% from the prior year.
- Assets Average for Q4 2025 stood at $10.1 million, down from $21.5 million in the prior quarter.
- The five-year high for Assets Average was $266.0 million in Q4 2021, with the low at $10.1 million in Q4 2025.
- The 5-year median for Assets Average is $178.8 million (2023), against an average of $148.5 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average advanced 2.33% in 2022, then sank 82.39% in 2025.
- BioAtla's Assets Average stood at $266.0 million in 2021, then fell by 22.02% to $207.4 million in 2022, then sank by 34.67% to $135.5 million in 2023, then sank by 57.69% to $57.3 million in 2024, then tumbled by 82.39% to $10.1 million in 2025.
- Business Quant data shows BCAB's Assets Average at $10.1 million in Q4 2025, $21.5 million in Q3 2025, and $32.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - | 4.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.92 Mn |
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 10.10 Mn |
| Sep 30, 2025 | 21.52 Mn |
| Jun 30, 2025 | 32.71 Mn |
| Mar 31, 2025 | 45.36 Mn |
| Dec 31, 2024 | 57.33 Mn |
| Sep 30, 2024 | 65.44 Mn |
| Jun 30, 2024 | 78.92 Mn |
| Mar 31, 2024 | 104.43 Mn |
| Dec 31, 2023 | 135.51 Mn |
| Sep 30, 2023 | 165.50 Mn |
| Jun 30, 2023 | 192.09 Mn |
| Mar 31, 2023 | 215.14 Mn |
| Dec 31, 2022 | 207.42 Mn |
| Sep 30, 2022 | 201.30 Mn |
| Jun 30, 2022 | 222.07 Mn |
| Mar 31, 2022 | 242.54 Mn |
| Dec 31, 2021 | 266.00 Mn |
| Sep 30, 2021 | 247.14 Mn |